Follow-up telephone interviews of 80 patients showed that on average these long-term survivors had a quality of life that closely matched historical octogenarian controls who had not undergone aortic valve implantation.
Transapical aortic valve implantation is a reasonable, minimally invasive option for high-risk patients, Dr. Walther concluded.
Disclosures: Dr. Walther has received honoraria from Edwards Lifesciences.